Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521372 · ClinicalTrials.gov registry record
The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
A clinical trial of Infertility Primary, sponsored by Ovation Fertility.
- Recruiting
- Registry status
- 450
- Enrollment target
- 3
- Study locations
NCT06521372: Recruiting study of Infertility Primary, sponsored by Ovation Fertility.
NCT06521372 is a study of Infertility Primary that is actively recruiting participants, run by Ovation Fertility. The registered enrollment target is 450 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06521372, a study of Infertility Primary, is actively recruiting participants, sponsored by Ovation Fertility.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 3
- Study locations
Study Summary
The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
Primary Outcome
Blast Development rates between oocytes (and resulting embryos) that are group cultured according to MagentaTM scores versus oocytes (and resulting embryos group) cultured as per the standard of care following random sorting. Blastocyst development is defined by an embryologist's grading, according to the laboratory's grading system.
Conditions Studied
Interventions
- OTHER Magenta AI image analysis tool
Study Locations (3)
Nevada
- Ovation Fertility Las Vegas - Las Vegas
Ohio
- Ovation Fertility Cincinnati - Cincinnati
Tennessee
- Ovation Fertility - Nashville - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-01-02 |
What NCT06521372 shows while recruiting
NCT06521372 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Infertility Primary appearing as the primary indexed condition, and to 1 intervention - of which Magenta AI image analysis tool is the first listed.
NCT06521372 reports a single indexed study location in Nevada, Ohio, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06521372 about?
NCT06521372 is a clinical study titled "The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF". The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
What is the current status of trial NCT06521372?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2024-01-01. Estimated completion is 2027-01-02.
What conditions does trial NCT06521372 study?
This clinical trial studies the following conditions: Infertility Primary.
What interventions are being tested in trial NCT06521372?
The interventions under investigation include: Magenta AI image analysis tool (OTHER).
Who is sponsoring clinical trial NCT06521372?
This trial is sponsored by Ovation Fertility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06521372 being conducted?
This trial has 3 study locations across Nevada, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility Primary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI